Areteia Therapeutics announces the appointment of Christopher Courts, CPA as Chief Financial Officer
Areteia Therapeutics announces the appointment of Christopher Courts, CPA as Chief Financial Officer. Christopher will report to Jorge Bartolome, CEO of Areteia Therapeutics, effective immediately.
Christopher is a seasoned industry executive with over 20 years of experience in public and private life science companies. Most recently, Christopher served as Chief Financial Officer at Pebble Labs, a biotech company creating safe and effective biological solutions to sustainably protect yields and quality in food production, where he led financial operations, strategic planning, and business development.
Prior to Pebble Labs, Christopher served as CFO and founding member of Regado Biosciences’ executive team. He was responsible for the company’s finance and accounting functions, as well as raising $260M in private and public equity financings. Christopher managed the S1 process culminating with the company’s successful IPO.
“I am delighted to be welcoming another experienced member to the executive team at Areteia Therapeutics,” said Jorge Bartolome, CEO of Areteia Therapeutics. He added “Chris will play an essential role in fulfilling our company’s mission to put asthma patients in better control of their disease and lives.”
About Areteia Therapeutics
Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing the first potential oral drug for eosinophilic asthma. Areteia’s lead drug candidate is dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences. A syndicate of leading life sciences and strategic investors led by Bain Capital Life Sciences with participation from Access Biotechnology, GV, ARCH Venture Partners, Saturn Partners, Sanofi, Maverick Capital, and Population Health Partners, has committed to invest up to $350 million in Series A financing to establish Areteia and advance dexpramipexole through Phase 3 clinical trials, secure commercial supply, and pursue potential next-generation medicines. Areteia will conduct late-stage development including Phase 3 clinical trials of dexpramipexole in partnership with Population Health Partners’ development unit, Validae Health.
About Dexpramipexole
Dexpramipexole is an oral small molecule in phase 3 development for eosinophilic asthma. Dexpramipexole inhibits the maturation and release of eosinophils in bone marrow, based on evidence from cell cultures and human biopsies, thereby lowering peripheral blood eosinophil levels. Most recently in a Phase 2 study in patients with moderate-to-severe eosinophilic asthma, treatment with dexpramipexole resulted in a significant, dose-dependent reduction in blood absolute eosinophil count at all doses tested (daily dexpramipexole doses of 37.5 mg, 75 mg, or 150 mg twice daily) compared to placebo. Dexpramipexole was well tolerated in the trial, with adverse events balanced across treatment and placebo groups, no serious adverse events, and no adverse events leading to discontinuation.
About Eosinophilic Asthma
Asthma disrupts the lives of more than a quarter of a billion people worldwide. More than half of asthma patients have eosinophilic asthma, which is driven by an oversupply of eosinophils, a type of white blood cell, in blood and tissue. By inhibiting the maturation of eosinophils, oral dexpramipexole acts in a way similar to injectable anti-IL-5 biologic therapies. The asthma biologic market is experiencing growth of 10% per year and is valued at around $8 billion, with IL-5 biologic therapies representing approximately $3 billion of that figure. If approved as a first-to-market oral, dexpramipexole could provide a compelling alternative to injectable biologics, and could potentially be used earlier in the asthma treatment paradigm to prevent progression of disease.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005055/en/
Contact information
Tamsin Berry
Tamsin.Berry@areteiatx.com
Mark Kreston
Mark.Kreston@areteiatx.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TOURISE and Oxford Economics Release White Paper Charting Tourism’s Path to Resilience and Stability Amid Global Volatility10.11.2025 18:10:00 EET | Press release
TOURISE, in collaboration with Oxford Economics, has released a new white paper titled “Growth Amid Uncertainty: Opportunities and Risks on the Road to 2 Billion Global Travellers,” unveiled during the inaugural TOURISE Summit. The publication presents key opportunities and risks that the industry will face in coming years as well as a framework to guide policymakers, destination leaders, and industry stakeholders in strengthening the tourism sector’s capacity to withstand global disruptions and foster long-term sustainability and resilience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110254503/en/ TOURISE and Oxford Economics Release White Paper Charting Tourism’s Path to Resilience and Stability Amid Global Volatility The white paper underscores the imperative of resilience as a foundational principle for tourism development in an era marked by geopolitical shifts, climate-related challenges, and evolving traveler e
Altman Solon Selects Mindbreeze to Power Knowledge Management and Collaboration Across the Organization10.11.2025 17:01:00 EET | Press release
Mindbreeze, a leading global provider of AI-based knowledge management solutions, today announced that Altman Solon, the world’s largest strategy consulting firm focused exclusively on telecommunications, media, and technology (TMT), has purchased Mindbreeze InSpire. The collaboration began in July 2025 with a trial of the Mindbreeze Insight Workplace, designed to unify Altman Solon’s SharePoint and web-based data sources into a single point of entry for organizational knowledge. Before partnering with Mindbreeze, Altman Solon sought to enhance how its global teams accessed and shared knowledge across systems, a challenge common among consulting firms with vast, fast-growing data ecosystems. The company had built a strong foundation in SharePoint for managing structured project data, but its native search capabilities limited visibility across platforms. Project information was distributed across several secure repositories, making it difficult to form a single, holistic view of our co
Decagon Announces Commercial Pilot with Deutsche Telekom and Strategic Investment from T.Capital to Fuel Enterprise Growth10.11.2025 17:00:00 EET | Press release
WEB SUMMIT 2025 – Decagon, the leader in conversational AI agents for concierge customer experiences, today announced a commercial pilot with global telecommunications provider Deutsche Telekom, as well as a strategic investment from T.Capital, the corporate venture arm of Deutsche Telekom. Deutsche Telekom is the world’s largest telecommunications provider by revenue and serves hundreds of millions of mobile customers across the globe. T.Capital provides early- and late-stage strategic capital to companies that have synergies with parent Deutsche Telekom. “Decagon’s powerful AI is helping businesses deliver an exceptional customer experience,” said Jonathan Abrahamson, Chief Product & Digital Officer at Deutsche Telekom. “The company's innovative approach fits perfectly to our own vision to elevate customer experiences through technology, and we look forward to both our commercial pilot and joining the roster of top-flight investors fueling the company’s impressive product velocity an
NIQ to Present at 2025 J.P. Morgan Ultimate Services Investor Conference10.11.2025 17:00:00 EET | Press release
NielsenIQ (NYSE: NIQ) (the “Company”, or "NIQ"), a leading global consumer intelligence company, today announced that Jim Peck, Chairman and CEO, will participate in a fireside chat at the J.P. Morgan Ultimate Services Investor Conference on Tuesday, November 18, 2025 at 10:20 am ET. A live webcast of the presentation will be available on the NIQ investor relations website at https://investors.nielseniq.com. A replay will also be available on the Company's website following the conclusion of the presentation. About NielsenIQ NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. Our global reach spans over 90 countries covering approximately 85% of the world’s population and more than $7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delive
Dawex and Innovalia Group Join Forces to Accelerate the Deployment of Data Exchange Solutions in Spain10.11.2025 16:07:00 EET | Press release
Dawex, the leader in data exchange solutions, and Innovalia Group, a strategic group of technology companies specializing in digital transformation solutions, have signed a strategic collaboration agreement to drive the development of secure and sovereign data spaces in the Spanish market through a comprehensive range of products and services. The collaboration brings together two strong and complementary areas of expertise: Dawex’s technological leadership in Data Exchange and the Innovalia Group’s extensive knowledge of the Spanish industrial sector. Dawex and the Innovalia Group are joining forces to offer joint value propositions to large companies, SMEs and public entities, interested in deploying their own digital ecosystems and secure, trusted data spaces. Dawex brings its extensive technology, business and regulatory expertise in creating secure and trusted data ecosystems, such as Corporate Data Hubs, Data Marketplaces and Industry Data Spaces, to create data spaces and improv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom